Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| EXELIXIS, INC. | 54,908 | reported | 21 Mar 2024 | tx 61+917,171−646,852 |
| VERTEX PHARMACEUTICALS INC / MA | 1,433 | reported | 01 May 2026 | tx 17+39,531 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 May 2026 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 472 | 0.00 USD | |
| 01 May 2026 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 1,433 | 0.00 USD | deriv |
| 01 May 2025 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 398 | 0.00 USD | |
| 01 May 2025 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 1,199 | 0.00 USD | deriv |
| 01 May 2024 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 3,142 | 0.00 USD | deriv |
| 21 Mar 2024 | SALE | EXELIXIS, INC. | 19,205 | 24.01 USD | |
| 21 Mar 2024 | EXERCISE | EXELIXIS, INC. | 23,491 | 19.57 USD | |
| 21 Mar 2024 | EXERCISE | EXELIXIS, INC. | 23,491 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | EXELIXIS, INC. | 44,087 | 0.00 USD | deriv |
| 01 May 2023 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 584 | 0.00 USD | |
| 01 May 2023 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 1,741 | 0.00 USD | deriv |
| 21 Feb 2023 | SALE | EXELIXIS, INC. | 40,000 | 17.49 USD | |
| 21 Feb 2023 | EXERCISE | EXELIXIS, INC. | 40,000 | 6.30 USD | |
| 21 Feb 2023 | EXERCISE | EXELIXIS, INC. | 40,000 | 0.00 USD | deriv |
| 26 May 2022 | GRANT_AWARD | EXELIXIS, INC. | 42,422 | 0.00 USD | deriv |
| 01 May 2022 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 4,462 | 0.00 USD | deriv |
| 01 Mar 2022 | EXERCISE | EXELIXIS, INC. | 40,000 | 3.13 USD | |
| 01 Mar 2022 | SALE | EXELIXIS, INC. | 21,301 | 21.00 USD | |
| 01 Mar 2022 | EXERCISE | EXELIXIS, INC. | 40,000 | 0.00 USD | deriv |
| 27 May 2021 | GRANT_AWARD | EXELIXIS, INC. | 33,549 | 0.00 USD | deriv |
| 01 May 2021 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 6,067 | 0.00 USD | deriv |
| 15 Mar 2021 | SALE | EXELIXIS, INC. | 40,000 | 23.60 USD | |
| 15 Mar 2021 | EXERCISE | EXELIXIS, INC. | 40,000 | 3.38 USD | |
| 15 Mar 2021 | EXERCISE | EXELIXIS, INC. | 40,000 | 0.00 USD | deriv |
| 01 Jun 2020 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 699 | 0.00 USD |